Cargando…

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection

Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in people with HIV (PWH) with a history of late presentation (LP) and their durability have not been fully characterized. DESIGN: In this prospective, longitudinal study, we sought to assess T-cell and hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Augello, Matteo, Bono, Valeria, Rovito, Roberta, Tincati, Camilla, d’Arminio Monforte, Antonella, Marchetti, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355808/ https://www.ncbi.nlm.nih.gov/pubmed/37199415 http://dx.doi.org/10.1097/QAD.0000000000003585

Ejemplares similares

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
por: Rovito, Roberta, et al.
Publicado: (2022)

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects
por: Bono, Valeria, et al.
Publicado: (2022)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
por: Tincati, Camilla, et al.
Publicado: (2012)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
por: Augello, Matteo, et al.
Publicado: (2023)

Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes
por: Ancona, Giuseppe, et al.
Publicado: (2021)

Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects
por: Mondatore, Debora, et al.
Publicado: (2022)

Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19
por: Marchetti, Giulia, et al.
Publicado: (2023)

Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
por: Rovito, Roberta, et al.
Publicado: (2022)

Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
por: Bai, Francesca, et al.
Publicado: (2012)

Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
por: Galassi, Andrea, et al.
Publicado: (2022)

Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
por: Tincati, Camilla, et al.
Publicado: (2020)

Predictors of low ovarian reserve in cART-treated women living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment
por: Tincati, Camilla, et al.
Publicado: (2014)

Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2016)

Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice
por: Falcinella, Camilla, et al.
Publicado: (2021)

Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
por: Basilissi, Matteo, et al.
Publicado: (2019)

Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
por: Merlini, Esther, et al.
Publicado: (2019)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients
por: Gazzola, Lidia, et al.
Publicado: (2013)

HIV-Indicator Condition Guided Testing in a Hospital Setting
por: Barbanotti, Diletta, et al.
Publicado: (2023)

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
por: Marchetti, Giulia, et al.
Publicado: (2012)

HIV-Infected Late Presenter Patients
por: D'Arminio Monforte, Antonella, et al.
Publicado: (2012)

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study
por: Marchetti, Giulia, et al.
Publicado: (2014)

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets
por: Cona, Andrea, et al.
Publicado: (2019)

Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus
por: Tincati, Camilla, et al.
Publicado: (2022)

Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers
por: d'Arminio Monforte, Antonella, et al.
Publicado: (2021)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
por: Ciceri, Paola, et al.
Publicado: (2022)

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
por: Saracino, Annalisa, et al.
Publicado: (2018)

Impact of daily versus weekly service of infectious diseases consultation on hospital antimicrobial consumption: a retrospective study
por: Cona, Andrea, et al.
Publicado: (2020)

Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio
por: Vergori, Alessandra, et al.
Publicado: (2023)

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
por: Mondi, Annalisa, et al.
Publicado: (2019)

The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Female gender is associated with long COVID syndrome: a prospective cohort study
por: Bai, Francesca, et al.
Publicado: (2022)

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis
por: Girardi, Enrico, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sq1bh9n5anqjrhm6e9jjuevlro